141 related articles for article (PubMed ID: 32699874)
1. Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds.
Schulz G; Victoria C; Kirschning A; Steinmann E
Nat Prod Rep; 2021 Jan; 38(1):18-23. PubMed ID: 32699874
[TBL] [Abstract][Full Text] [Related]
2. Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species.
Pan L; Woodard JL; Lucas DM; Fuchs JR; Kinghorn AD
Nat Prod Rep; 2014 Jul; 31(7):924-39. PubMed ID: 24788392
[TBL] [Abstract][Full Text] [Related]
3. 1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties.
Nilewski C; Michels TD; Packard GK; Xiang AX; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Ernst JT; Reich SH
Bioorg Med Chem Lett; 2021 Sep; 47():128111. PubMed ID: 34353608
[TBL] [Abstract][Full Text] [Related]
4. Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor Silvestrol.
Müller C; Obermann W; Schulte FW; Lange-Grünweller K; Oestereich L; Elgner F; Glitscher M; Hildt E; Singh K; Wendel HG; Hartmann RK; Ziebuhr J; Grünweller A
Antiviral Res; 2020 Mar; 175():104706. PubMed ID: 31931103
[TBL] [Abstract][Full Text] [Related]
5. Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.
Islam MT; Sarkar C; El-Kersh DM; Jamaddar S; Uddin SJ; Shilpi JA; Mubarak MS
Phytother Res; 2020 Oct; 34(10):2471-2492. PubMed ID: 32248575
[TBL] [Abstract][Full Text] [Related]
6. Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity.
Callahan KP; Minhajuddin M; Corbett C; Lagadinou ED; Rossi RM; Grose V; Balys MM; Pan L; Jacob S; Frontier A; Grever MR; Lucas DM; Kinghorn AD; Liesveld JL; Becker MW; Jordan CT
Leukemia; 2014 Oct; 28(10):1960-8. PubMed ID: 24577530
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of rocaglamide hydroxamates and related compounds as eukaryotic translation inhibitors: synthetic and biological studies.
Rodrigo CM; Cencic R; Roche SP; Pelletier J; Porco JA
J Med Chem; 2012 Jan; 55(1):558-62. PubMed ID: 22128783
[TBL] [Abstract][Full Text] [Related]
8. Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from
Greger H
Phytochem Rev; 2022; 21(3):725-764. PubMed ID: 34104125
[TBL] [Abstract][Full Text] [Related]
9. New rocaglamide derivatives from Vietnamese Aglaia species.
Duong NT; Edrada-Ebel R; Ebel R; Lin W; Duong AT; Dang XQ; Nguyen NH; Proksch P
Nat Prod Commun; 2014 Jun; 9(6):833-4. PubMed ID: 25115092
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Zika Virus Replication by Silvestrol.
Elgner F; Sabino C; Basic M; Ploen D; Grünweller A; Hildt E
Viruses; 2018 Mar; 10(4):. PubMed ID: 29584632
[TBL] [Abstract][Full Text] [Related]
11. Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells.
Blum L; Geisslinger G; Parnham MJ; Grünweller A; Schiffmann S
J Cell Mol Med; 2020 Jun; 24(12):6988-6999. PubMed ID: 32374474
[TBL] [Abstract][Full Text] [Related]
12. Silvestrol Inhibits Chikungunya Virus Replication.
Henss L; Scholz T; Grünweller A; Schnierle BS
Viruses; 2018 Oct; 10(11):. PubMed ID: 30380742
[TBL] [Abstract][Full Text] [Related]
13. The natural compound silvestrol is a potent inhibitor of Ebola virus replication.
Biedenkopf N; Lange-Grünweller K; Schulte FW; Weißer A; Müller C; Becker D; Becker S; Hartmann RK; Grünweller A
Antiviral Res; 2017 Jan; 137():76-81. PubMed ID: 27864075
[TBL] [Abstract][Full Text] [Related]
14. Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses.
Müller C; Schulte FW; Lange-Grünweller K; Obermann W; Madhugiri R; Pleschka S; Ziebuhr J; Hartmann RK; Grünweller A
Antiviral Res; 2018 Feb; 150():123-129. PubMed ID: 29258862
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic rocaglamide derivatives from Aglaia duppereana.
El-Neketi M; Ebrahim W; Duong NT; Gedara S; Badria F; Saad HE; Müller WE; Proksch P
Z Naturforsch C J Biosci; 2013; 68(7-8):269-74. PubMed ID: 24066511
[TBL] [Abstract][Full Text] [Related]
16. Known Triterpenes and their Derivatives as Scaffolds for the Development of New Therapeutic Agents for Cancer.
Peron G; Marzaro G; Dall Acqua S
Curr Med Chem; 2018; 25(10):1259-1269. PubMed ID: 28820068
[TBL] [Abstract][Full Text] [Related]
17. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
[TBL] [Abstract][Full Text] [Related]
18. Total synthesis of the potent anticancer Aglaia metabolites (-)-silvestrol and (-)-episilvestrol and the active analogue (-)-4'-desmethoxyepisilvestrol.
Adams TE; El Sous M; Hawkins BC; Hirner S; Holloway G; Khoo ML; Owen DJ; Savage GP; Scammells PJ; Rizzacasa MA
J Am Chem Soc; 2009 Feb; 131(4):1607-16. PubMed ID: 19140688
[TBL] [Abstract][Full Text] [Related]
19. Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A.
Basmadjian C; Thuaud F; Ribeiro N; Désaubry L
Future Med Chem; 2013 Dec; 5(18):2185-97. PubMed ID: 24261894
[TBL] [Abstract][Full Text] [Related]
20. Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris.
Hwang BY; Su BN; Chai H; Mi Q; Kardono LB; Afriastini JJ; Riswan S; Santarsiero BD; Mesecar AD; Wild R; Fairchild CR; Vite GD; Rose WC; Farnsworth NR; Cordell GA; Pezzuto JM; Swanson SM; Kinghorn AD
J Org Chem; 2004 May; 69(10):3350-8. PubMed ID: 15132542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
